Circulating MicroRNAs in gynecological malignancies: From detection to prediction

Experimental Hematology and Oncology

Volumn 3, Issue 1, 2014, Pages

  Zhao, Ya Nan ^a,b   Chen, Guan Sheng ^a,b   Hong, Shun Jia ^a,b  

^a SUN YAT SEN MEMORIAL HOSPITAL OF SUN YAT SEN UNIVERSITY   (China)

^b SUN YAT SEN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA; MICRORNA 100; MICRORNA 141; MICRORNA 155; MICRORNA 200A; MICRORNA 200B; MICRORNA 200C; MICRORNA 203; MICRORNA 20A; MICRORNA 542 3P; MICRORNA 646; SQUAMOUS CELL CARCINOMA ANTIGEN; UNCLASSIFIED DRUG;

CANCER DIAGNOSIS; CANCER PROGNOSIS; CANCER SURVIVAL; DISEASE ASSOCIATION; ENDOMETRIUM CARCINOMA; HUMAN; INTERMETHOD COMPARISON; MOLECULAR DIAGNOSIS; OVARY CANCER; PRIORITY JOURNAL; REVIEW; SURVIVAL PREDICTION; UTERINE CERVIX CANCER;

EID: 84978023669     PISSN: None     EISSN: 21623619     Source Type: Journal    
DOI: 10.1186/2162-3619-3-14     Document Type: Review

References (35)

1. Siegel R, Ma J, Zou Z, Jemal A. Cancer statistics, 2014. CA Cancer J Clin 2014, 64:9-29. 10.3322/caac.21208, 24399786.
2. Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004, 116:281-297. 10.1016/S0092-8674(04)00045-5, 14744438.
3. Zhang H, Chen Z, Wang X, Huang Z, He Z, Chen Y. Long non-coding RNA: a new player in cancer. J Hematol Oncol 2013, 6:37. 10.1186/1756-8722-6-37, 3693878, 23725405.
4. Hayashita Y, Osada H, Tatematsu Y, Yamada H, Yanagisawa K, Tomida S, Yatabe Y, Kawahara K, Sekido Y, Takahashi T. A polycistronic microRNA cluster, miR-17-92, is overexpressed in human lung cancers and enhances cell proliferation. Cancer Res 2005, 65:9628-9632. 10.1158/0008-5472.CAN-05-2352, 16266980.
5. Hassan O, Ahmad A, Sethi S, Sarkar FH. Recent updates on the role of microRNAs in prostate cancer. J Hematol Oncol 2012, 5:9. 10.1186/1756-8722-5-9, 3313897, 22417299.
6. Akao Y, Nakagawa Y, Hirata I, Iio A, Itoh T, Kojima K, Nakashima R, Kitade Y, Naoe T. Role of anti-oncomirs miR-143 and -145 in human colorectal tumors. Cancer Gene Ther 2010, 17:398-408. 10.1038/cgt.2009.88, 20094072.
7. Sun YM, Lin KY, Chen YQ. Diverse functions of miR-125 family in different cell contexts. J Hematol Oncol 2013, 6:6. 10.1186/1756-8722-6-6, 3566921, 23321005.
8. Gimenes-Teixeira HL, Lucena-Araujo AR, Dos SG, Zanette DL, Scheucher PS, Oliveira LC, Dalmazzo LF, Silva-Junior WA, Falcao RP, Rego EM. Increased expression of miR-221 is associated with shorter overall survival in T-cell acute lymphoid leukemia. Exp Hematol Oncol 2013, 2:10. 10.1186/2162-3619-2-10, 3637292, 23566596.
9. Mitchell PS, Parkin RK, Kroh EM, Fritz BR, Wyman SK, Pogosova-Agadjanyan EL, Peterson A, Noteboom J, O'Briant KC, Allen A, Lin DW, Urban N, Drescher CW, Knudsen BS, Stirewalt DL, Gentleman R, Vessella RL, Nelson PS, Martin DB, Tewari M. Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci U S A 2008, 105:10513-10518. 10.1073/pnas.0804549105, 2492472, 18663219.
10. Patel RS, Jakymiw A, Yao B, Pauley BA, Carcamo WC, Katz J, Cheng JQ, Chan EK. High resolution of microRNA signatures in human whole saliva. Arch Oral Biol 2011, 56:1506-1513. 10.1016/j.archoralbio.2011.05.015, 3189266, 21704302.
11. Wang G, Chan ES, Kwan BC, Li PK, Yip SK, Szeto CC, Ng CF. Expression of microRNAs in the urine of patients with bladder cancer. Clin Genitourin Cancer 2012, 10:106-113. 10.1016/j.clgc.2012.01.001, 22386240.
12. Hausler SF, Keller A, Chandran PA, Ziegler K, Zipp K, Heuer S, Krockenberger M, Engel JB, Honig A, Scheffler M, Dietl J, Wischhusen J. Whole blood-derived miRNA profiles as potential new tools for ovarian cancer screening. Br J Cancer 2010, 103:693-700. 10.1038/sj.bjc.6605833, 2938264, 20683447.
13. Taylor DD, Gercel-Taylor C. MicroRNA signatures of tumor-derived exosomes as diagnostic biomarkers of ovarian cancer. Gynecol Oncol 2008, 110:13-21. 10.1016/j.ygyno.2008.04.033, 18589210.
14. Cannistra SA. Cancer of the ovary. N Engl J Med 2004, 351:2519-2529. 10.1056/NEJMra041842, 15590954.
15. Resnick KE, Alder H, Hagan JP, Richardson DL, Croce CM, Cohn DE. The detection of differentially expressed microRNAs from the serum of ovarian cancer patients using a novel real-time PCR platform. Gynecol Oncol 2009, 112:55-59. 10.1016/j.ygyno.2008.08.036, 18954897.
16. Chung YW, Bae HS, Song JY, Lee JK, Lee NW, Kim T, Lee KW. Detection of microRNA as novel biomarkers of epithelial ovarian cancer from the serum of ovarian cancer patients. Int J Gynecol Cancer 2013, 23:673-679. 10.1097/IGC.0b013e31828c166d, 23542579.
17. Shapira I, Oswald M, Lovecchio J, Khalili H, Menzin A, Whyte J, Dos SL, Liang S, Bhuiya T, Keogh M, Mason C, Sultan K, Budman D, Gregersen PK, Lee AT. Circulating biomarkers for detection of ovarian cancer and predicting cancer outcomes. Br J Cancer 2014, 110:976-983. 10.1038/bjc.2013.795, 3929876, 24366298.
18. Suryawanshi S, Vlad AM, Lin HM, Mantia-Smaldone G, Laskey R, Lee M, Lin Y, Donnellan N, Klein-Patel M, Lee T, Mansuria S, Elishaev E, Budiu R, Edwards RP, Huang X. Plasma microRNAs as novel biomarkers for endometriosis and endometriosis-associated ovarian cancer. Clin Cancer Res 2013, 19:1213-1224. 10.1158/1078-0432.CCR-12-2726, 3596045, 23362326.
19. Zheng H, Zhang L, Zhao Y, Yang D, Song F, Wen Y, Hao Q, Hu Z, Zhang W, Chen K. Plasma miRNAs as diagnostic and prognostic biomarkers for ovarian cancer. PLoS One 2013, 8:e77853. 10.1371/journal.pone.0077853, 3815222, 24223734.
20. Shen W, Song M, Liu J, Qiu G, Li T, Hu Y, Liu H. MiR-26a promotes ovarian cancer proliferation and tumorigenesis. PLoS One 2014, 9:e86871. 10.1371/journal.pone.0086871, 3899311, 24466274.
21. Kan CW, Hahn MA, Gard GB, Maidens J, Huh JY, Marsh DJ, Howell VM. Elevated levels of circulating microRNA-200 family members correlate with serous epithelial ovarian cancer. BMC Cancer 2012, 12:627. 10.1186/1471-2407-12-627, 3542279, 23272653.
22. Hong F, Li Y, Xu Y, Zhu L. Prognostic significance of serum microRNA-221 expression in human epithelial ovarian cancer. J Int Med Res 2013, 41:64-71. 10.1177/0300060513475759, 23569131.
23. Guo F, Tian J, Lin Y, Jin Y, Wang L, Cui M. Serum microRNA-92 expression in patients with ovarian epithelial carcinoma. J Int Med Res 2013, 41:1456-1461. 10.1177/0300060513487652, 23963852.
24. Xu YZ, Xi QH, Ge WL, Zhang XQ. Identification of serum microrna-21 as a biomarker for early detection and prognosis in human epithelial ovarian cancer. Asian Pac J Cancer Prev 2013, 14:1057-1060. 10.7314/APJCP.2013.14.2.1057, 23621186.
25. Amant F, Moerman P, Neven P, Timmerman D, van Limbergen E, Vergote I. Endometrial cancer. Lancet 2005, 366:491-505. 10.1016/S0140-6736(05)67063-8, 16084259.
26. Bansal N, Yendluri V, Wenham RM. The molecular biology of endometrial cancers and the implications for pathogenesis, classification, and targeted therapies. Cancer Control 2009, 16:8-13.
27. Zhai H, Karaayvaz M, Dong P, Sakuragi N, Ju J. Prognostic significance of miR-194 in endometrial cancer. Biomark Res 2013, 1:12. 10.1186/2050-7771-1-12, 3772652,3772652, 24040515.
28. Tan ZQ, Liu FX, Tang HL, Su Q. [Expression and its clinical significance of hsa-miR-155 in serum of endometrial cancer]. Zhonghua Fu Chan Ke Za Zhi 2010, 45:772-774.
29. Torres A, Torres K, Pesci A, Ceccaroni M, Paszkowski T, Cassandrini P, Zamboni G, Maciejewski R. Deregulation of miR-100, miR-99a and miR-199b in tissues and plasma coexists with increased expression of mTOR kinase in endometrioid endometrial carcinoma. BMC Cancer 2012, 12:369. 10.1186/1471-2407-12-369, 3495850, 22920721.
30. Torres A, Torres K, Pesci A, Ceccaroni M, Paszkowski T, Cassandrini P, Zamboni G, Maciejewski R. Diagnostic and prognostic significance of miRNA signatures in tissues and plasma of endometrioid endometrial carcinoma patients. Int J Cancer 2013, 132:1633-1645. 10.1002/ijc.27840, 22987275.
31. Tsukamoto O, Miura K, Mishima H, Abe S, Kaneuchi M, Higashijima A, Miura S, Kinoshita A, Yoshiura KI, Masuzaki H. Identification of endometrioid endometrial carcinoma-associated microRNAs in tissue and plasma. Gynecol Oncol 2014, 132:715-721. 10.1016/j.ygyno.2014.01.029, 24491411.
32. Wang WT, Zhao YN, Yan JX, Weng MY, Wang Y, Chen YQ, Hong SJ. Differentially expressed microRNAs in the serum of cervical squamous cell carcinoma patients before and after surgery. J Hematol Oncol 2014, 7:6. 10.1186/1756-8722-7-6, 3892020, 24405714.
33. Yu J, Wang Y, Dong R, Huang X, Ding S, Qiu H. Circulating microRNA-218 was reduced in cervical cancer and correlated with tumor invasion. J Cancer Res Clin Oncol 2012, 138:671-674. 10.1007/s00432-012-1147-9, 22237456.
34. Zhao S, Yao D, Chen J, Ding N. Circulating miRNA-20a and miRNA-203 for screening lymph node metastasis in early stage cervical cancer. Genet Test Mol Biomarkers 2013, 17:631-636. 10.1089/gtmb.2013.0085, 23819812.
35. Chen J, Yao D, Li Y, Chen H, He C, Ding N, Lu Y, Ou T, Zhao S, Li L, Long F. Serum microRNA expression levels can predict lymph node metastasis in patients with early-stage cervical squamous cell carcinoma. Int J Mol Med 2013, 32:557-567. 3782554, 23799609.